Clinical Trial: DETERMINATION VALUES FOR SKELETAL MUSCLE MASS INDEX IN TURKISH POPULATION USING DUAL ENERGY X RAY ABSORPTIOMETRY

U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT07510009) titled 'DETERMINATION VALUES FOR SKELETAL MUSCLE MASS INDEX IN TURKISH POPULATION USING DUAL ENERGY X RAY ABSORPTIOMETRY' on March 28.

Brief Summary: Sarcopenia is defined by the European Working Group on Sarcopenia in Older People (EWGSOP) as "a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength, carrying a risk of adverse outcomes such as physical disability, fractures, falls, impaired quality of life, and death." However, despite the severity of the disease, a single diagnostic criterion has not yet been established, and various guidelines have been proposed to standardize the diagnostic crite...